1Department of Physiology, Veterinary School, and 2Inserm U211, Nantes, France Summary. Antibodies to pancreatic islet cells were visualized, using an immunohistochemical method with the avidin-biotin-peroxidase complex, either in the islets or sera of diabetic C57BL/KsJ db/db mice. They were revealed within the cytoplasm of all islet ,cell types. Anti-islet complement-dependent antibodies were demonstrated in vitro in the sera of the same db/db mice. These anomalies were not detected in control littermates. During the life span of db/db mice, cell-bound antibodies were present at early stages, co-existing with hyperinsulinaemia, islet hypertrophy and decreased insulin content of cells. Circulating antibodies were detectable later, before the development of insulinopenia, islet atrophy and cell necrosis. The titre of the immunohistochemically detected complement-fixing antibodies and their lytic potency for islet cells in vitro increased with age. This is the first time that antibodies to islet cells have been revealed within the islets of diabetic animals. Furthermore, anti-islet cell autoantibodies appear very early in db/db islets and may be implicated in the pathogenesis of this murine diabetic syndrome.
The diabetic syndrome produced in C57 BLKsJ mice by the autosomal recessive mutation db is characterized by islet hyperplasia and hyperinsulinaemia in early stages followed by later ]?-cell necrosis, decreased plasma insulinaemia, and enhanced hyperglycaemia [1] . In db/db mice, cellular and humoral autoimmunities were demonstrated to destroy islet cells and to alter insulin release in vitro [2] . Concomitantly, thymic dysfunctions were documented [3] .
The aim of this study was to visualize autoantibodies bound to the islets of db/db mice, to assess their complement-fixing ability and to determine target cell types. The age-related changes in antibodies were explored by a highly sensitive immunoperoxidase procedure with an avidin-biotin horseradish peroxidase complex [4] . These data were compared, during the life span of db/db mice, with metabolic and histological anomalies and with circulating humoral autoimmunity.
Materials and methods

Mice
C57BL/KsJ db/db, db/+ and +/+ mice were bred at the Veterinary School, Nantes. Weight, blood glucose and plasma insulin levels were screened in 12-h fasted mice. An insulin/glucose index was calculated.
Histology and immunohistoehemistry
To analyse the islet cell populations, an immunoperoxidase technique was used. Bouin-fixed pancreatic sections (5 lxm thick) were incubated for t h with anti-insulin, glucagon and somatostatin sera (respectively diluted: 1:200, 1:20, 1:20 in phosphate buffered saline) and then exposed for 1 h to biotinylated goat anti-rabbit, or anti-guinea pig IgG sera diluted 1 : 200 (Vector Laboratory, Burlingame, California, USA). After a further 45 min incubation with avidin-biotin horseradish peroxidase complex (dilution 1:50, Vector Laboratory), sections were treated for 15 rain with I mg/ml diaminobenzidine (Sigma, St. Louis, Missouri, USA) and 0.03% H202. Antibodies bound in db/ db islets were revealed by an immunoperoxidase assay [4] . Bouinfixed pancreatic sections were incubated for 15min with normal horse serum, diluted 1 : 50. They were then exposed for 1 h to biotinylated horse anti-mouse IgG serum (diluted t : 200), followed by incubation with avidin-biotin horseradish peroxidase complex and development of the brown colour with diaminobenzidine and H202. To detect antibodies in db/db sera, Bouin-fixed pancreatic sections from control mice were incubated for 3 h with serum (diluted 1 : 50) before exposure to biotinylated antiserum and colour development. Deposits of complement in db/db islets were looked for on snap-frozen sections using the immunoperoxidase method [4] with rabbit antimouseC3c serum (Nordic, Tilburg, The Netherlands; diluted 1:100) and biotinylated goat anti-rabbit IgG serum. Target cells were determined by two methods, the detection of antibodies being carried out with diaminobenzidine as described above. The first procedure was a double-labelling immunoperoxidase technique [5] , in which sections brown-stained for antibodies were then incubated for 1 h with either anti-insulin, anti-glucagon or anti-somatostatin sera. Reactions were processed for 1 h with biotinylated antisera and visualised by a blue colour obtained using 0.03% 4-chloro 1-naphtol (Sigma) and 0.03% H202 for 10 min. In the second procedure, anti-hormone sera were put on adjacent sections to those stained for bound antibodies. All conventional controls were carried out. Between all steps, slides were washed in phosphate buffered saline (pH 7.4). Endogenous peroxidase activity was blocked with methanol and 0.3% H202. All slides were monitored with a light microscope.
Complement-dependent humoral chromium 51 release test
To perform a 51Cr release test [6] , 106 islet cells prepared from d b / + mice as described previously [7] , were labelled for 1 h with 0.1 mCi of Na2 51Cr 04. After washing, cells were resuspended in microplates (5 x 103/well in 1001xl MEM Eagle's medium, Flow Laboratories, Rockville, Maryland, USA) and incubated for 40 rain with 15 lxl test sera. Frozen guinea-pig serum (85 lxl diluted 1:8) was added as a source of complement. After 30 min, supernatants were counted in a gamma counter. The 51Cr release was compared with that of cells lysed by distilled water. Experiments were performed in triplicate. Statistical significance was calculated using the Student's t-test.
Results
Age-related metabolic and histological changes
From day 10 to 1 year of life, db/db mice displayed hyperinsulinaemia compared to d b / + control mice. From week 5 to 1 year, weight and blood glucose levels were higher in the db/db mice than in the control mice. The insulin/glucose index was higher in young, but lower in old db/db mice, than in control mice. Compared with control mice, age-related changes were noted in islets from db/db mice using the immunoperoxidase procedures. Before 5 months, db/db mice displayed hypertrophy and hyperplasia of the islets together with an increased number and a decreased insulin content of fl cells. After 6 months, the islets displayed a progressive atrophy and the number of/~ cells was marked-ly decreased. At i year, db/db islets were dislocated and vacuolised. No insulitis was found.
Immunoperoxidase study of antibodies bound to islet cells
Islets of control mice did not contain antibodies as demonstrated by the absence of staining after the immunoperoxidase procedure (Fig.1 a) . In contrast, in db/db islets at 3 weeks, antibodies were detectable by the brown labelLling of some islet cells. This staining extended progressively with age and covered all the cells in the hypertrophic islets in 5-month-old db/db mice (Fig. 1 b) . In older mice, the staining became again confined to a few cells and disappeared from dislocated and vacuolized islets. This labelling was detectable in the cytoplasm of the cells. The complement-fixation immunoperoxidase method produced a brown colour in db/db islets revealing that some of the antibodies, but not all, were complement-fixing. During these immunoperoxidase experiments, the labelling of db/db islets disappeared when biotinylated anti-mouse IgG antiserum was omitted, suggesting that the above staining was not due to the binding of the exogenous avidin to tissue biotin.
Identification of target islet cells
The double-labelling immunoperoxidase technique revealed that the staining for antibodies was not confined to fl cells, but was shared by other endocrine cells.
Immunoperoxidase detection of circulating ICA
Incubation of db/db sera, but not control sera, with Bouin-fixed or frozen control pancreatic sections, gave a brown colour in the islets, revealing the presence of circulating antibodies to islet cells. This staining was no longer obtained when db/db sera were pre-incubated with islet cells before the immunoperoxidase assay, but was still present after pre-incubation with excess insulin. This detection of circulating antibodies was not possible before the fourth month, but its intensity then increased reaching a maximum by 1 year. However, even this maximal staining was weaker than when the deposition of IgG was revealed in the islets of db/db mice.
Complement-dependent lytic potency of circulating antibodies
The 51Cr release from islet cells incubated with complement, in the absence of mouse serum, was 35_+1% (n = 10). This release was not modified by control sera, in the presence of complement. In contrast, the 51Cr release was increased by db/db sera + complement. This release was detectable from the fourth month (p< 0.01) and increased with age, reaching 49_+1% with sera from 12-month-old mice. When complement was omitted, the 5~Cr release was not modified by db/db sera.
Discussion
The present study gives the first description of IgG deposition in the islets of a diabetic animal. Islet cell antibodies were visualised, using an immunoperoxidase method, bound either to the islets or in the sera from db/db mice. They bound to all islet cell types. Some of them were complement-fixing antibodies.
The staining obtained was cytoplasmic. However, this cytoplasmic binding of antibodies should be interpreted with caution since other studies have proved that methods of tissue fixation can modify dramatically the binding of even a single anti-islet antibody. Concomitantly, circulating antibodies were demonstrated to increase the 5~Cr release from islet cells in the presence of complement. As previously described [2] , sera from these db/db mice also altered the insulin release from/3 cells in the presence of complement or of mononuclear cells (data not shown). An age-related association appeared between islet bound and circulating antibodies which were revealed later than the former. This earlier detectability of bound antibodies may reflect a trapping of autoantibodies on their targets, whereas they may be rapidly cleared from the circulation and thus revealed with more difficulty. Bound antibodies were found on hyperplastic islets several months before islet atrophy and H-cell necrosis. The significance of these antibodies cannot be concluded from the present study. However, some of them were not complement-fixing. Furthermore, in the case of cytolytic antibodies, one must be impressed by the long latency period between their binding to islet cells and subsequent islet atrophy. The increasing titre of antibodies throughout the life span of db/db mice revealed a sustained stimulation of humoral autoimmunity. Although the immunohistochemical staining for the antibodies was cytoplasmic, the target antigen(s) is still unknown. Further investigation is needed to understand the relationship between anti-islet cell immunity and hyperinsulinaemia, in the absence of hyperglycaemia, at the beginning of the db/db mouse's life. Hyperinsulinaemia cannot solely result from overweight and insulin resistance since it precedes the development of obesity. To date the impossible dissociation between the onset of hyperinsulinaemia and anti-islet cell immunity remains compatible with a causal role of the immune process in this double-stage murine diabetic syndrome. The db/db mouse differs considerably from the human Type 1 diabetic patient and the diabetic BB rat, where anti-islet immunity is associated with early insulinopenia and insulitis [8, 9] .
